
Neuroendocrine cancer of maxillary sinus: case report and literature review
Author(s) -
Т. И. Дешкина,
L. V. Bolotina,
А. Р. Геворков,
A. V. Boiko,
В. С. Суркова,
Michaela Šedová,
A. Polyakov,
A. L. Kornietskaya,
А. А. Феденко
Publication year - 2022
Publication title -
opuholi golovy i šei
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 1
eISSN - 2411-4634
pISSN - 2222-1468
DOI - 10.17650/2222-1468-2021-11-4-110-118
Subject(s) - nasal cavity , medicine , paranasal sinuses , maxillary sinus , neuroendocrine carcinoma , neuroendocrine tumors , chemoradiotherapy , cancer , sinus (botany) , pathology , basal cell , radiation therapy , radiology , carcinoma , surgery , biology , botany , genus
Malignant tumors of the sinuses and nasal cavity are rare diseases. Squamous cell carcinoma is the most common histological type (55–70 % of tumors of the sinuses and nasal cavity). The frequency of neuroendocrine tumors reaches 5 %. Currently, there is no generally accepted standard for the treatment of neuroendocrine tumors of sinonasal localization. If surgical treatment is associated with a significant deterioration of the quality of life or poor outcomes, chemoradiotherapy can be recommended. This article describes a clinical case of combined treatment of neuroendocrine cancer of the maxillary sinus and brief review of the literature on malignant tumors of the paranasal sinuses and the nasal cavity.